• Je něco špatně v tomto záznamu ?

MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer

S. Lettlova, V. Brynychova, J. Blecha, D. Vrana, M. Vondrusova, P. Soucek, J. Truksa,

. 2018 ; 46 (6) : 2601-2615. [pub] 20180507

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033082

Grantová podpora
NV17-28470A MZ0 CEP - Centrální evidence projektů

BACKGROUND/AIMS: MiRNA-301a-3p is an oncogenic miRNA whose expression is associated with tumor development, metastases and overall poor prognosis. Estrogen receptor α (ERα) is one of the estrogen hormone-activated transcription factors, which regulates a large number of genes and is involved in the mammary gland development. Expression of ERα is considered to be a good indicator for endocrine therapy and breast cancer survival. Loss of ERα in breast cancer patients indicates invasiveness and poor prognosis. In this study, we focus on the regulation of ERα by miR-301a and its role in transition from estrogen-dependent to estrogen-independent breast cancer. METHODS: Expression of miR-301a-3p was measured by qRT-PCR in tumor tissue samples from 111 patients with primary breast carcinoma and in mammospheres representing in vitro model of cancer stem-like cells. Dual reporter luciferase assay and complementary experiments were performed to validate ESR1 as a direct target of miR-301a-3p. The effect of miR-301a-3p on estrogen signaling was evaluated on the level of gene and protein expression and growth response to estrogens. Finally, the effect of miR-301a-3p expression on tumor growth was studied in nude mice. RESULTS: We identified ESR1 as a direct target of miR-301a-3p. Ectopic miR-301a-3p causes a decrease in ESR1 mRNA and protein level and modulates the expression of ERα target genes in ERα positive breast cancer cells. Consistently, miR-301a-3p causes a decrease in sensitivity of MCF7 cells to 17β-estradiol and inhibits the growth of estrogen dependent tumor in nude mice. Yet, the mice tumors have significantly increased expression of genes related to cancer stem-like cells and epithelial to mesenchymal transition suggesting enrichment of the population of cells with more invasive properties, in line with our observation that miR-301a-3p expression is highly increased in mammospheres which show a decrease in estrogenic signaling. Importantly, miR-301a-3P level is also increased in primary breast cancer samples exhibiting an ER/PR negative phenotype. CONCLUSION: Our results confirm ESR1 as a direct target of miR-301a-3p and suggest that miR-301a-3p likely contributes to development of estrogen independence, which leads to a more invasive phenotype of breast cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033082
003      
CZ-PrNML
005      
20181023105527.0
007      
ta
008      
181008s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000489687 $2 doi
035    __
$a (PubMed)29763890
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lettlova, Sandra $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer / $c S. Lettlova, V. Brynychova, J. Blecha, D. Vrana, M. Vondrusova, P. Soucek, J. Truksa,
520    9_
$a BACKGROUND/AIMS: MiRNA-301a-3p is an oncogenic miRNA whose expression is associated with tumor development, metastases and overall poor prognosis. Estrogen receptor α (ERα) is one of the estrogen hormone-activated transcription factors, which regulates a large number of genes and is involved in the mammary gland development. Expression of ERα is considered to be a good indicator for endocrine therapy and breast cancer survival. Loss of ERα in breast cancer patients indicates invasiveness and poor prognosis. In this study, we focus on the regulation of ERα by miR-301a and its role in transition from estrogen-dependent to estrogen-independent breast cancer. METHODS: Expression of miR-301a-3p was measured by qRT-PCR in tumor tissue samples from 111 patients with primary breast carcinoma and in mammospheres representing in vitro model of cancer stem-like cells. Dual reporter luciferase assay and complementary experiments were performed to validate ESR1 as a direct target of miR-301a-3p. The effect of miR-301a-3p on estrogen signaling was evaluated on the level of gene and protein expression and growth response to estrogens. Finally, the effect of miR-301a-3p expression on tumor growth was studied in nude mice. RESULTS: We identified ESR1 as a direct target of miR-301a-3p. Ectopic miR-301a-3p causes a decrease in ESR1 mRNA and protein level and modulates the expression of ERα target genes in ERα positive breast cancer cells. Consistently, miR-301a-3p causes a decrease in sensitivity of MCF7 cells to 17β-estradiol and inhibits the growth of estrogen dependent tumor in nude mice. Yet, the mice tumors have significantly increased expression of genes related to cancer stem-like cells and epithelial to mesenchymal transition suggesting enrichment of the population of cells with more invasive properties, in line with our observation that miR-301a-3p expression is highly increased in mammospheres which show a decrease in estrogenic signaling. Importantly, miR-301a-3P level is also increased in primary breast cancer samples exhibiting an ER/PR negative phenotype. CONCLUSION: Our results confirm ESR1 as a direct target of miR-301a-3p and suggest that miR-301a-3p likely contributes to development of estrogen independence, which leads to a more invasive phenotype of breast cancer.
650    _2
$a 3' nepřekládaná oblast $7 D020413
650    _2
$a zvířata $7 D000818
650    _2
$a nádory prsu $x genetika $x metabolismus $x patologie $7 D001943
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a alfa receptor estrogenů $x analýza $x genetika $x metabolismus $7 D047628
650    _2
$a estrogeny $x metabolismus $7 D004967
650    _2
$a ženské pohlaví $7 D005260
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši nahé $7 D008819
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brynychova, Veronika $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Olomouc, Czech Republic.
700    1_
$a Blecha, Jan $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
700    1_
$a Vrana, David $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
700    1_
$a Vondrusova, Magdalena $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
700    1_
$a Soucek, Pavel $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Olomouc, Czech Republic.
700    1_
$a Truksa, Jaroslav $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
773    0_
$w MED00173244 $t Cellular physiology and biochemistry international journal of experimental cellular physiology, biochemistry, and pharmacology $x 1421-9778 $g Roč. 46, č. 6 (2018), s. 2601-2615
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29763890 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181023110034 $b ABA008
999    __
$a ok $b bmc $g 1340792 $s 1030076
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 46 $c 6 $d 2601-2615 $e 20180507 $i 1421-9778 $m Cellular physiology and biochemistry $n Cell Physiol Biochem $x MED00173244
GRA    __
$a NV17-28470A $p MZ0
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace